The Bank of England on Thursday said it was cutting its key interest further after UK inflation hit a three-year low and ...

Find insight on Domain, Sensata Technologies and more in the latest Market Talks covering Technology, Media and Telecom.

Chevron's strategic moves and positive developments position the company for growth and success, making it a strong choice ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...

Khel Now is back with another analysis of the Indian football team players. Here's a look at the performances of players for National team!

With their innovative technology ASX medical imaging companies are capitalising on billions of dollars in contracts annually being awarded to companies by the US Department of Veterans Affairs.

Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in ...

The FDA has lifted clinical holds on trials of zevor-cel, satri-cel, and CT071, and trials will now resume in the US.

Cipla share price had fallen after the company's September quarter results as analysts cut their target price, citing weaker than expected domestic business and challenges in its key products.

The clearance of Cipla's Goa facility opens the doors for the launch of Abraxane, which could be a around $120 million opportunity at peak.

Leading drug maker Cipla shares today saw a steep rally of 10% after the USFDA classified its Goa facility as a Voluntary ...

Adams said he believed it was unlikely that Kennedy could be appointed to lead a major health agency because he has no medical expertise, it would likely be difficult for him to pass a background ...